0 rating

Clinical Observations

The Framingham cardiovascular risk score in multiple sclerosis.

Moccia M, Lanzilloa R, Palladino R et al.

Federico II University, Naples, Italy.

 Eur J Neurol 2015;22:1176–83.

Melinda Magyari’s review: The main aim of this study was to assess the global cardiovascular risk in persons with multiple sclerosis (MS) using the Framingham Risk Score (FRS), a standardized algorithm estimating an individual’s percentage risk of experiencing cardiovascular events (coronary, cerebrovascular, peripheral arterial disease, or heart failure) in the next 10 years (Circulation 2008;117:743–53). A higher risk of cardiovascular comorbidities in patients with MS has been reported in previous studies, and vascular comorbidities seem to influence disability development and progression (Neurology 2010;74:1041–7).

Return to top


The Role of B Cells in Multiple Sclerosis: Experimental and Clinical Aspects
Til Menge, MD, Gerd Meyer zu Hörste, MD, and Bernd C Kieseier, MD
CML Multiple Sclerosis
Pharmacogenomics in Multiple Sclerosis
Manuel Comabella, MD and Xavier Montalban, MD
CML Multiple Sclerosis
The Role of MRI as a Predictive Marker for Disease Progression Measured by the Expanded Disability Status Scale
Antonia Ceccarelli, MD, Domenico Caputo, MD, and Marco Rovaris, MD
CML Multiple Sclerosis
Advances in Multiple Sclerosis Therapy: New Oral Disease-Modifying Agents
Andreas Lutterotti, MD and Thomas Berger, MD, MSc
CML Multiple Sclerosis
Optical Coherence Tomography as a Marker of Axonal Damage in Multiple Sclerosis
Shiv Saidha, MRCPI, Christopher Eckstein, MD, and John N Ratchford, MD
CML Multiple Sclerosis